Cited by 50Medicinal Plant Extracts EffectsStress Responses and CortisolMedicinal Plants and Bioactive Compounds

The depressive-like behaviors of chronic unpredictable mild stress-treated mice ameliorated by Tibetan medicine Zuotai: involvement in the hypothalamic–pituitary–adrenal (HPA) axis pathway

Open access
Zhao, Jing, Niu, Cuiying, Wang, Jianv, Yang, Hongxia, Du, Yuzhi, Wei, Lixin, Li, Cen·2018·Neuropsychiatric Disease and Treatment

Abstract

BACKGROUND: Zuotai, a famous Tibetan medicinal mixture containing metacinnabar, is traditionally used for the purpose of tranquilizing minds and soothing nerves. However, it still lacks substantial experimental data for it to be approved for use. AIM: This study was designed to assess the effects of Zuotai on depressive-like symptoms in a chronic unpredictable mild stress (CUMS) mouse model, and to explore its potential mechanism, particularly the hypothalamic-pituitary-adrenal (HPA) axis pathway. MATERIALS AND METHODS: First, Kunming mice were exposed to the CUMS procedure and simultaneously administered Zuotai or imipramine (positive control) by gavage continuously for 6 weeks. Then, depressive-like behaviors of mice in each group were tested with the sucrose preference test, forced swimming test, tail suspension test, and open field test. Meanwhile, the three key neuroendocrine hormones (corticotropin releasing hormone, adrenocorticotropic hormone and corticosterone) in HPA axis pathway, and the level of the emotion-related monoamine neurotransmitters (5-hydroxytryptamine and norepinephrine) were measured using enzyme-linked immunosorbent assay. Furthermore, total mercury in the hypothalamus and hippocampus were determined using an automatic, direct mercury analyzer. RESULTS: Zuotai or imipramine significantly increased the body weight and the sucrose preference ratio in sucrose preference test, and dramatically improved motor activity in forced swimming test, tail suspension test, and open field test in CUMS mice. Zuotai or imipramine remarkably decreased levels of corticotropin-releasing hormone, adrenocorticotropic hormone, and corticosterone in the HPA axis, and increased levels of 5-hydroxytryptamine and norepinephrine in the serum in CUMS mice. However, a small amount of mercury was deposited in the hypothalamus and hippocampus in Zuotai-treated mice, which may pose a potential risk to the central nervous system. CONCLUSION: Zuotai has a strong ability to ameliorate depressive-like behaviors in CUMS-treated mice through inhibition of the HPA axis and upregulation of monoamine neurotransmitters. These findings provide new insight into the pharmacological effect of Zuotai on depression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ndt.s151107

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Prenatal stress-induced HPA hyperreactivity coexists with alterations in HDAC/DNMT activity.

    “Animal studies demonstrate that prenatal stress-induced HPA hyperreactivity coexists with alterations in HDAC/DNMT activity”

    From Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook (2026) · cites this paper as Zhao et al., 2018

    The Introduction (page unavailable) says chronic adverse stress can cause HPA-axis hyperactivity. It does not identify that stress as prenatal, and the passages retrieved from our copy do not address HDAC or DNMT activity or its coexistence with HPA hyperreactivity. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • There is emerging evidence for the use of modular, trans-diagnostic psychological treatments (compared with 'disorder' specific treatments).

    “and emerging evidence for the use of modular, trans-diagnostic psychological treatments (compared with 'disorder' specific treatments). 692”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [13]Lanke Brief review of Tibetan medicine Zuotai Chin J Ethnomed Ethnopharm 1999 5 Suppl 86 Available from: http://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFQ&dbname=CJFD9899&filename=ZMYZ1999S1083&uid=WEEvREcwSlJHSldRa1FhcTdWZDhML1N0TTlaTDVQYStZMUFMVHR6cS9GUT0=$9A4hF_YAuvQ-5obgVAqNKPCYcEjKensW4ggI8Fm4gTkoUKaID8j8gFw!!&v=M-TI4NzVUcldNMUZyQ1VSTDJlWnVkckZ5em1XN3JKUHlEU2RM-S3hGOWl2cm85Tlo0UjhlWDFMdXhZUzdEaDFUM3E= Accessed November 20, 2017 Chinese

Cited by

Sorted by citations

Authors
Zhao, J., Niu, C., Wang, J., Yang, H., Du, Y., Wei, L., & Li, C.
Affiliations
  • Chinese Academy of Sciences (CN)
  • University of Chinese Academy of Sciences (CN)
Corresponding author
  • Wei, Lixin
  • Li, Cen
Venue
Neuropsychiatric Disease and Treatment
Published
2018-01
Volume
Volume 14
Pages
129-141
ISSN
  • 1176-6328 (ISSN-L)
  • 1178-2021
OpenAlex
W2782432378
Cited by
49
References
49
Citations by year
2026: 4 · 2025: 3 · 2024: 6 · 2023: 7 · 2022: 8 · 2021: 5 · 2020: 6 · 2019: 9 · 2018: 1
FWCI
7.21
Type
journal article
Language
en
Open access
Locations
  • Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
  • National Natural Science Foundation of China (81374063, 2017-ZJ-Y08)
  • Chinese Academy of Sciences (Y529021211, 2017-ZJ-Y08, 81374063, 2016-ZJ-919Q)
  • National Institutes of Health
  • National Institute of Environmental Health Sciences
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Medicinal Plants and Bioactive Compounds
Keywords
Tibetan medicine, metacinnabar, chronic unpredictable mild stress, depression, depression-like behavior, hypothalamic-pituitary-adrenal axis, corticotropin-releasing factor, ACTH, corticosterone, serotonin, norepinephrine, mercury accumulation, hypothalamus, hippocampus, imipramine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review